Nathan Tal

Title: Nathan Tal: Innovator in Soluble LDL Receptor Research

Introduction

Nathan Tal is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of biomedicine, particularly in the development of soluble LDL receptors. With a total of 4 patents to his name, Tal's work focuses on innovative solutions for protecting mammals against viral infections.

Latest Patents

Among his latest patents is the invention titled "Soluble LDL receptor, its production and use." This patent details the DNA encoding a soluble LDL receptor protein, along with vectors, cell lines, and processes for its production. The soluble LDL receptor protein, along with its muteins and fragments, is designed to provide protection against viral infections in mammals. Another notable patent is also titled "Soluble LDL receptor, its production and use," which describes a soluble LDL receptor protein that can be isolated from cells treated with interferon, from the urine of healthy individuals, or produced through recombinant techniques. This protein serves a similar purpose in protecting mammals from viral infections.

Career Highlights

Nathan Tal is associated with Yeda Research and Development Co. Ltd., where he continues to advance his research and innovations. His work has garnered attention in the scientific community for its potential applications in healthcare and disease prevention.

Collaborations

Tal has collaborated with notable colleagues, including Menachem Rubinstein and Daniela Novick, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Nathan Tal's contributions to the field of soluble LDL receptor research highlight his role as an influential inventor. His patents not only advance scientific knowledge but also hold promise for future medical applications.